EVAX
Evaxion Biotech AS
NASDAQ: EVAX · HEALTHCARE · BIOTECHNOLOGY
$4.41
+3.52% today
Updated 2026-04-30
Market cap
$33.61M
P/E ratio
—
P/S ratio
4.47x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$1 – $12
Volume
0.0M
Evaxion Biotech AS (EVAX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-40.7%
Last 4 quarters
Revenue YoY growth
-81.9%
Most recent quarter
EPS YoY growth
+85.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+5.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+12.7%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.01 | +0.0% | $4.78 | $4.71 | -1.5% |
| 2025-11-06 | $0.50 | +600.0% | $5.66 | $6.38 | +12.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.01 | $-0.01 | +0.0% | $22040.00 | -81.9% |
| 2025-09-30 | $-0.10 | $0.50 | +600.0% | $7.49M | +148.3% |
| 2025-06-30 | $-0.45 | $-1.00 | -122.2% | $37000.00 | -76.0% |
| 2025-03-31 | $-0.71 | $-3.14 | -345.9% | $122000.00 | +139.8% |
| 2024-12-31 | $-0.15 | $-0.07 | +53.3% | $122000.00 | +67.1% |
| 2024-09-30 | $-0.31 | $-0.04 | +87.1% | $3.02M | — |
| 2024-06-30 | $-0.39 | $-0.12 | +69.2% | $154000.00 | — |
| 2024-03-31 | $-0.56 | $0.30 | +153.6% | $50881.00 | — |
| 2023-12-31 | $-1.60 | $-1.60 | +0.0% | $73000.00 | — |
| 2023-09-30 | $-0.19 | $-0.21 | -10.5% | — | — |
| 2023-06-30 | $-0.21 | $-0.21 | +0.0% | — | — |
| 2023-03-31 | $-0.24 | $-0.24 | +0.0% | — | — |
Frequently asked questions
Has Evaxion Biotech AS beaten earnings estimates?
Evaxion Biotech AS has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -40.7% over the last 3 quarters.
How does EVAX stock react to earnings?
EVAX stock has moved an average of +5.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Evaxion Biotech AS's revenue growth rate?
Evaxion Biotech AS reported year-over-year revenue growth of -81.9% in its most recent quarter, with EPS growing +85.7% year-over-year.